Donna Senger, University of Calgary

Research

Intravital Imaging Chronic Kidney Disease Chronic Lung Disease Critical Illness Inflammation Therapeutics Cancer Metastasis Leukocytes

Latest papers

ADAM-9 is a novel mediator of tenascin-C-stimulated invasiveness of brain tumor-initiating cells.
Neuro-oncology · 2015
Population-based study of medulloblastoma: outcomes in Alberta from 1975 to 1996.
The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques · 2008

All 2 publications

Latest funding

Therapeutic Targeting a Shared Inflammation Pathway in the Lung and Kidney
CIHR · 2021 · Principal investigator
$750,000
Molecular mechanisms underlying liver and lung-specific metastasis
CIHR · 2019 · Nominated PI
$937,125
Non-classical mechanisms for leukocyte recruitment in the lungs: therapeutic targets for attenuating acute lung injury
CIHR · 2019 · Nominated PI
$879,750

All 3 grants and awards

2 publications.

01

ADAM-9 is a novel mediator of tenascin-C-stimulated invasiveness of brain tumor-initiating cells.

Sarkar S, Zemp FJ, Senger D, Robbins SM, Yong VW

Neuro-oncology2015

DOI: 10.1093/neuonc/nou362 PMID: 25646025

02

Population-based study of medulloblastoma: outcomes in Alberta from 1975 to 1996.

Roldán G, Brasher P, Vecil G, Senger D, Rewcastle B, Cairncross G, Forsyth P, Hamilton M

The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques2008

DOI: 10.1017/s0317167100008659 PMID: 18574936

Therapeutic Targeting a Shared Inflammation Pathway in the Lung and Kidney

Principal investigatorCIHR2021Team Grant: Preparation to Trial: Inflammation for Chronic Conditions

Principal investigators: Muruve, Daniel A; Kubes, Paul; Senger, Donna L

Keywords: Chronic Kidney Disease; Chronic Lung Disease; Critical Illness; Inflammation; Therapeutics

$750,000

Molecular mechanisms underlying liver and lung-specific metastasis

Nominated PICIHR2019Project Grant

Principal investigators: Senger, Donna L

Keywords: Cancer Metastasis; Intravital Imaging; Leukocytes; Neutrophils; Organ-Selective Metastasis; Tumor Microenvironment

$937,125

Non-classical mechanisms for leukocyte recruitment in the lungs: therapeutic targets for attenuating acute lung injury

Nominated PICIHR2019Project Grant

Principal investigators: Senger, Donna L

Keywords: Acute Lung Injury; Dipeptidase-1; Endotoxemia; Intravital Imaging; Leukocyte Recruitment; Lung Vasculature; Sepsis

$879,750

From CIHR, NSERC and SSHRC funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998, including their latest published competition results.

Frequent collaborators

Gregory Cairncross

Faculty

1 shared papers, latest 2008

Write to this professor

A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.

Applying for

Paper to mentionMention their CIHR grant from 2021

Subject: Prospective PhD student: Intravital Imaging Dear Professor Senger, My name is [your name], and I am a [your current degree or role] at [your institution]. I am applying for a PhD position starting in [term and year]. I read your paper "ADAM-9 is a novel mediator of tenascin-C-stimulated invasiveness of brain tumor-initiating cells." (2015), and it connects closely to my own work on [your research topic]. [One or two sentences on what you did and what you learned.] I also saw your CIHR-funded project "Therapeutic Targeting a Shared Inflammation Pathway in the Lung and Kidney" (2021), and I would be glad to contribute to work in that direction. Are you accepting new PhD students for [term and year]? I have attached my CV and transcripts, and I would be glad to talk at a time that suits you. Thank you for your time. Kind regards, [your name]